ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Society guideline links: Diagnosis and management of prostate cancer

Society guideline links: Diagnosis and management of prostate cancer

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Screening for prostate cancer".)

International

European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Geriatric Oncology (SIOG): Guidelines on prostate cancer, update (2023)

World Health Organization (WHO): Classification of tumours – Urinary and male genital tumours, 5th edition (2022)

WHO: Classification of tumours of the urinary system and male genital organs – Part B: Prostate and urinary tract tumors (2022)

SIOG: Updated recommendations on prostate cancer management in older patients (2019)

SIOG: Position paper on radiopharmaceuticals in the elderly cancer patient – Practical considerations, with a focus on prostate cancer therapy (2017)

Society for Immunotherapy of Cancer (SITC): Consensus statement on immunotherapy for the treatment of prostate carcinoma (2016)

Canada

Canadian Urological Association (CUA): Best practice report on bone health in prostate cancer (2021)

Choosing Wisely Canada: Don't do routine bone scans in men with low-risk prostate cancer (2021)

Choosing Wisely Canada: Don't initiate management in patients with low-risk prostate cancer (T1/T2, PSA <10 ng/ml, and Gleason score <7) without first discussing active surveillance (2021)

Choosing Wisely Canada: Don't order a routine bone scan and CT scan of the pelvis in men with low-risk prostate cancer (2020)

CUA-Canadian Urologic Oncology Group (CUOG): Guideline on metastatic castration-naïve and castration-sensitive prostate cancer (2020)

CUA-CUOG: Guideline for management of castration-resistant prostate cancer (CRPC) (2019)

Cancer Care Ontario (CCO): Biodegradable rectal spacers for prostate cancer radiotherapy (2019)

American Society of Clinical Oncology (ASCO)/CCO: Joint guideline on brachytherapy for patients with prostate cancer, update (2017)

CCO: Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management (2017)

CCO: Performance of needle biopsy of the prostate for men with suspected or established prostate cancer (2017)

CCO: Bone health and bone-targeted therapies for prostate cancer (2016)

CCO: Magnetic resonance imaging for pre-treatment local staging of prostate cancer (2016)

CCO: Referral of suspected prostate cancer by family physicians and other primary care providers (2016)

CCO: Follow-up care and psychosocial needs of survivors of prostate cancer (2015)

CCO: Multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer (2015)

ASCO and CCO: Systemic therapy in men with metastatic castration-resistant prostate cancer (2014)

CCO: Active surveillance for the management of localized prostate cancer (2014)

CCO: Risk reduction of prostate cancer with drugs or nutritional supplements (2012)

United States

National Cancer Institute (NCI): Prostate cancer – Health professional version

American College of Clinical Oncology (ASCO): Guideline for initial management of noncastrate advanced, recurrent, or metastatic prostate cancer, update (2023)

American Urological Association (AUA)/Society of Urologic Oncology (SUO): Guideline on advanced prostate cancer (2020, amended 2023)

American College of Radiology (ACR): ACR Appropriateness Criteria on post-treatment follow-up on prostate cancer (revised 2022)

ACR: ACR Appropriateness Criteria on prostate cancer – Pretreatment detection, surveillance, and staging (revised 2022)

AUA/American Society for Radiation Oncology (ASTRO): Guideline on clinically localized prostate cancer (2022)

Part I – Introduction, risk assessment, staging, and risk-based management

Part II – Principles of active surveillance, principles of surgery, and follow-up

Part III – Principles of radiation and future directions

ASCO: Bone health and bone-targeted therapies for prostate cancer – Endorsement of a Cancer Care Ontario (CCO) guideline (2020)

ASCO: Guideline on optimum imaging strategies for advanced prostate cancer (2020)

Philadelphia Prostate Cancer Consensus Conference: Implementation of germline testing for prostate cancer, 2019 (published 2020)

ASTRO/AUA: Guideline on adjuvant and salvage radiotherapy after prostatectomy (2013, amended 2019)

ASCO: Molecular biomarkers in localized prostate cancer (2019)

AUA/Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU): Guideline on incontinence after prostate treatment (2019)

ASTRO, ASCO, and AUA: Evidence-based guideline on hypofractionated radiation therapy for localized prostate cancer (2018)

ASCO: Clinically localized prostate cancer – Clinical practice guideline endorsement of an AUA/ASTRO/SUO guideline (2018)

ASCO: Provisional clinical opinion on second-line hormonal therapy for men with chemotherapy naïve, castration-resistant prostate cancer (2017)

ASCO/Cancer Care Ontario (CCO): Joint guideline on brachytherapy for patients with prostate cancer, update (2017)

American Cancer Society (ACS): Prostate cancer survivorship care guidelines (2014)

ASCO and CCO: Systemic therapy in men with metastatic castration-resistant prostate cancer (2014)

American Brachytherapy Society (ABS): Consensus guidelines for high-dose-rate prostate brachytherapy (2012)

ABS: Consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy (2012)

Europe

European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Geriatric Oncology (SIOG): Guidelines on prostate cancer, update (2023)

European Society for Medical Oncology (ESMO): Updated treatment recommendations for prostate cancer from the ESMO clinical practice guideline considering treatment intensification and use of novel systemic agents (2023)

ESMO: Prostate cancer – Clinical practice guidelines for diagnosis, treatment, and follow-up (2020)

European Organisation for Research and Treatment of Cancer (EORTC): Guidelines for target volume definition in post-operative radiotherapy for prostate cancer (2007)

United Kingdom

National Institute for Health and Care Excellence (NICE): Guideline on prostate cancer – Diagnosis and management (2019, updated 2021)

NICE: Quality standard on prostate cancer (2015, updated 2021)

Prostate Cancer UK: Consensus statements on PSA testing in asymptomatic men in the UK – Information for health professionals (2016)

Australia–New Zealand

Choosing Wisely Australia: Don't initiate management of low risk prostate cancer without discussing active surveillance (2021)

Australian and New Zealand Faculty of Radiation Oncology Genito-Urinary Group (FROGG): Guidelines on radiotherapy for node-positive prostate cancer – Recommendations (2019)

Royal Australian College of General Practitioners (RACGP): Guidelines for preventive activities in general practice, 9th edition (2018)

Prostate cancer

Prostate Cancer Foundation of Australia (PCFA) and Cancer Council Australia (CCA): Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer (2016)

Prostate Cancer Working Group and Ministry of Health: Guidance on using active surveillance to manage men with low-risk prostate cancer (2015)

Prostate Cancer Working Group and Ministry of Health: Prostate cancer management and referral guidance (2015)

Australian National Health and Medical Research Council (NHMRC): Prostate-specific antigen (PSA) testing in asymptomatic men (2014)

Prostate Cancer Taskforce: Diagnosis and management of prostate cancer in New Zealand men – Recommendations (2013)

CCA and Australian Cancer Network (ACN): Clinical practice guidelines for the management of locally advanced and metastatic prostate cancer (2010)

Japan

[In English] Japanese Urological Association (JUA): Evidence-based clinical practice guideline for prostate cancer, 2016 edition (published 2017)

[In Japanese] Choosing Wisely Japan: Low-risk prostate cancer – Do not be rushed (2016)

[In Japanese] JUA: Clinical practice guideline for prostate cancer (2016)

Topic 117831 Version 48.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟